GGrantIndex
Sort

8,912 grants matching sars cov 2

Africa Center for Biostatistical Excellence: Expanding biostatistical leadership for HIV/AIDS and TB Research

$299,412
Taryn Natalie Young · Stellenbosch University · D43 · FY2023 · TW

SARS-CoV-2 testing at the Seattle Vaccine and Prevention CRS (30331)

$299,401
Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · UM1 · FY2020 · AI

Modulation of chronic inflammatory responses by COVID19

$299,397
Mariana Kaplan · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2024 · AR

An internet-based preconception cohort study in North America and Denmark

$299,328
Lauren A Wise · Boston University Medical Campus · R01 · FY2021 · HD

SCH: Wearables for Health and Disease Knowledge (W4H)

$299,322
Cyrus Shahabi · University Of Southern California · R01 · FY2024 · LM

Targeting inflammation and oxidative stress to treat acute lung injury with CNP-miR146a

$299,271
David Jackson · Ceria Therapeutics, Inc. · R43 · FY2022 · HL

Rapid Genetic Fingerprinting of SARS-Cov-2 Variants

$299,200
Evgeni Veniaminovic Sokurenko · Idgenomics, Inc. · R41 · FY2021 · AI

mRNA Delivery of a Panel of Single-Domain Antibodies for Combinatorial Deciphering of Therapeutic Targets for Covid-19 Related Cytokine Release Syndrome

$299,128
Xiang Gao · Oncotrap, Inc. · R43 · FY2022 · AI

Outreach Core

$299,098
Noe Cuauhtemoc Crespo · San Diego State University · U54 · FY2021 · CA

Increasing COVID-19 vaccine uptake through a patient navigation intervention among underserved populations

$299,098
Hala Madanat · San Diego State University · U54 · FY2021 · CA

Rapid Autopsy

$299,086
Jody Elizabeth Hooper · Johns Hopkins University · P30 · FY2025 · CA

Flu Vaccine Production Using a Novel Pandemic Response and Prevention Manufacturing Method

$298,891
Michael Artinger · Solaris Vaccines, Inc. · R43 · FY2023 · AI

A biophysical assay targeting SARS CoV-2 RNA

$298,689
Sandra Paige Story · Nubad, Llc · R43 · FY2023 · AI

HEU outcomes: population-evaluation and screening strategies (HOPE)

$298,428
Grace C John-Stewart · University Of Washington · R33 · FY2023 · HD

Research Core 1: Molecular Measures Core (RC1)

$298,414
Virginia B. Kraus · Duke University · P30 · FY2023 · AG

Microbiology and Immunology Training for HIV and HIV-Related Research in Uganda (MITHU)

$298,161
W. Henry Henry Boom · Case Western Reserve University · D43 · FY2022 · TW

NeuroMAP Phase II - Recruitment and Assessment Core

$298,027
Robin L Aupperle · Laureate Institute For Brain Research · P20 · FY2025 · GM

Next generation implicit solvation for atomistic modeling

$297,987
Alexey Vlad Onufriev · Virginia Polytechnic Inst And St Univ · R01 · FY2024 · GM

Biology of ACE2 activity in the airway epithelium

$297,872
Paul B McCray · University Of Iowa · P01 · FY2012 · AI

Rapid, versatile PCR

$297,872
Gregory W Faris · Numentus Technologies Inc. · R43 · FY2024 · AI

Monoclonal antibody isolation and characterization for COVID-19 Effort

$297,871
Rosemarie Mason · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Role of Endothelial eNAMPT/NAMPT secretion and TLR4 signaling in the ARDS Vascular Endotype

$297,844
Joe G. N. Garcia · University Of Florida · P01 · FY2024 · HL

Microbiology and Immunology Training for HIV and HIV-Related Research in Uganda (MITHU)

$297,837
W. Henry Henry Boom · Case Western Reserve University · D43 · FY2025 · TW

California National Primate Research Center

$297,763
Prasant Mohapatra · University Of California At Davis · P51 · FY2022 · OD

Integrin Activation to Augment SARS-CoV-2 Vaccination

$297,724
Upendra Marathi · 7 Hills Pharma, Llc · R43 · FY2021 · AI